Skip to main content English


Hannah Christina Puhr Hannah Christina PuhrResident physician and PhD student

Department of Medicine I (Division of Oncology)
Position: Doctor-in-training

ORCID: 0000-0002-7203-8732
T +43 1 40400 44450


gastric cancer; oesophageal cancer

Research interests

My main research focus is to understand the importance of immunological and clinical parameters in gastroesophageal cancer. The overall aim of my work is to find novel prognostic factors and, thus, improve management of patients with gastroesophageal cancer.


  • Age dependent epigenetic drivers of gastroesophageal cancer progression (2021)
    Source of Funding: Medical Scientific Fund of the Mayor of the City of Vienna, Research grant of the city of Vienna for innovative, interdisciplinary cancer research
    Principal Investigator
  • Immunological, genetic and prognostic factors related to outcome in patients with upper gastrointestinal tract cancer (2021)
    Source of Funding: City of Vienna, PhD Martina Hamböck Grant of the Austrian Medical Chamber
    Principal Investigator

Selected publications

  1. Puhr, H.C. et al. (2022) ‘Development of an alarm symptom-based risk prediction score for localized oesophagogastric adenocarcinoma (VIOLA score)’, ESMO Open, 7(4), p. 100519. Available at:
  2. Puhr, H.C. et al. (2020) ‘Clinical characteristics and comparison of the outcome in young versus older patients with upper gastrointestinal carcinoma’, Journal of Cancer Research and Clinical Oncology, 146(12), pp. 3313–3322. Available at:
  3. Puhr, H.C. et al. (2022) ‘Absorption of Direct Oral Anticoagulants in Cancer Patients after Gastrectomy’, Pharmaceutics, 14(3), p. 662. Available at:
  4. Puhr, H.C. et al. (2020) ‘Viennese risk prediction score for Advanced Gastroesophageal carcinoma based on Alarm Symptoms (VAGAS score): characterisation of alarm symptoms in advanced gastro-oesophageal cancer and its correlation with outcome’, ESMO Open, 5(2), p. e000623. Available at:
  5. Puhr, H.C. et al. (2019) ‘Elevated Free Thyroxine Levels Are Associated with Poorer Overall Survival in Patients with Gastroesophageal Cancer: A Retrospective Single Center Analysis’, Hormones and Cancer, 11(1), pp. 42–51. Available at: